Table 1.

AD case demographics and neuropathological characteristics for transcriptomics

	APOE	Age	Sex	Braak stage
APOE2 carriers	2/3	93	F	3
	2/3	92	F	6
	2/3	92	F	3
	2/3	90	F	2
	2/3	91	F	5
	2/3	96	M	5
	2/3	67	M	6
	2/3	94	M	3
Age ± SD (years)		89.38 ± 9.2
PMI (range; mean) hours		1.4-3.3; 2.48
APOE3/3	3/3	80	F	6
	3/3	87	F	6
	3/3	81	F	6
	3/3	91	F	6
	3/3	89	F	6
	3/3	80	F	6
	3/3	80	F	6
	3/3	86	M	6
	3/3	85	M	6
	3/3	83	M	6
	3/3	81	M	6
	3/3	92	M	6
Age ± SD (years)		84.5 ± 4.4
PMI (range; mean) hours		2-9; 4.08
APOE4 carriers	3/4	83	F	6
	3/4	80	F	6
	3/4	89	F	6
	3/4	88	F	6
	3/4	84	F	6
	3/4	89	F	6
	3/4	90	F	6
	3/4	87	F	6
	3/4	88	M	6
	3/4	79	M	6
	3/4	76	M	6
	3/4	82	M	6
	3/4	84	M	6
	3/4	91	M	6
	3/4	80	M	6
	3/4	79	M	6
	4/4	79	F	6
	4/4	80	F	6
	4/4	82	M	6
	4/4	82	M	6
	4/4	84	M	6
	4/4	84	M	6
Age ± SD (years)		83.6 ± 4.2
PMI (range; mean) hours		1-15; 4035